Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 9879
Country/Region: Uganda
Year: 2015
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Prevention: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 6,962
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 432
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 3,567
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 361
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 11,322
CARE_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 11,322
CARE_NEW_DSD Aggregated Age/sex: 15+ Female 2016 1,340
CARE_NEW_DSD Aggregated Age/sex: 15+ Male 2016 809
CARE_NEW_DSD Aggregated Age/sex: <15 Female 2016 79
CARE_NEW_DSD Aggregated Age/sex: <15 Male 2016 56
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,284
CARE_NEW_DSD Sum of Aggregated Age/sex disaggregates 2016 2,284
CARE_NEW_TA Sum of Aggregated Age/sex disaggregates 2016 2,284
FN_THER_DSD Aggregated Age: 18+ 2016 159
FN_THER_DSD Aggregated Age: <18 2016 111
FN_THER_DSD Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 270
FN_THER_DSD Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 3,394
FN_THER_DSD Sum of Aggregated Age disaggregates 2016 270
PP_PREV_DSD Age/sex: 15-19 Female 2016 480
PP_PREV_DSD Age/sex: 15-19 Male 2016 538
PP_PREV_DSD Age/sex: 20-24 Female 2016 699
PP_PREV_DSD Age/sex: 20-24 Male 2016 558
PP_PREV_DSD Age/sex: 25-49 Female 2016 1,000
PP_PREV_DSD Age/sex: 25-49 Male 2016 1,028
PP_PREV_DSD Age/sex: 50+ Female 2016 68
PP_PREV_DSD Age/sex: 50+ Male 2016 89
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 4,460
PP_PREV_DSD Sum of Age/Sex disaggregates 2016 4,460
PP_PREV_DSD Total number of people in the target population 2016 12,880
TB_ART_DSD Aggregated Age: 15+ 2016 226
TB_ART_DSD Aggregated Age: <15 2016 21
TB_ART_DSD Female 2016 163
TB_ART_DSD Male 2016 84
TB_ART_DSD Sum of Aggregated Age disaggregates 2016 247
TB_ART_DSD Sum of Sex disaggregates 2016 247
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 314
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 247
TB_SCREEN_DSD Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 10,528
TB_SCREEN_DSD Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 794
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 11,322
TB_SCREEN_DSD Sex: Female 2016 7,391
TB_SCREEN_DSD Sex: Male 2016 3,931
TB_SCREEN_DSD Sum of Aggregated Age disaggregates 2016 11,322
TB_SCREEN_DSD Sum of Sex disaggregates 2016 11,322
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 11,322
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2016 3,113
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2016 6,762
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 10,659
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2016 9,875
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 9,875
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2016 946
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2016 2,004
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,082
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2016 2,950
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 3,666
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 4,318
VMMC_CIRC_DSD By circumcision technique: Device-based VMMC 2016 558
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2016 5,020
VMMC_CIRC_DSD By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 5,020
VMMC_CIRC_DSD By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 1,227
VMMC_CIRC_DSD By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 4,251
VMMC_CIRC_DSD By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 100
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 5,578